SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Free Cash Flow Generation Index

Latest as of December 2025: 0.15x

SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Free Cash Flow Generation Index of 0.15x as of December 2025. Free cash flow of €764.78 Million represents 0% of operating cash flow (€5.21 Billion). Read total liabilities of SHANG.FOS.PHARM.GR.H YC 1 for a breakdown of total debt and financial obligations.

FCF Generation Index

0.15x
Free Cash Flow / Operating CF

Free Cash Flow

€764.78 Million
EUR

Operating Cash Flow

€5.21 Billion
EUR

Capital Expenditures

€4.45 Billion
EUR

SHANG.FOS.PHARM.GR.H YC 1 Free Cash Flow Generation Index (2021–2025)

Historical FCF Generation Index trend for SHANG.FOS.PHARM.GR.H YC 1 across 5 annual periods. Explore reinvestment intensity of SHANG.FOS.PHARM.GR.H YC 1 to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)

Year-by-year Free Cash Flow Generation Index for SHANG.FOS.PHARM.GR.H YC 1. For the full company profile including market capitalisation, see 08HH stock market capitalisation.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 0.15x €764.78 Million €5.21 Billion €4.45 Billion ▲ +883.3%
2024 0.01x €66.79 Million €4.48 Billion €4.41 Billion ▲ +102.6%
2023 -0.56x €-1.92 Billion €3.41 Billion €5.34 Billion ▼ -42.1%
2022 -0.40x €-1.67 Billion €4.22 Billion €5.89 Billion ▼ -50.8%
2021 -0.26x €-1.03 Billion €3.94 Billion €4.97 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).